Researchers have long believed that the sleep disturbances common among the elderly often result from a disruption of the body’s circadian rhythms—biological…
“We found that adding gefinitib to standard chemotherapy was well-tolerated by patients who had already received chemotherapy or were frail,” said Dr. Argiris….
A vaccine for one of the most lethal cancers, advanced melanoma, has shown improved response rates and progression-free survival for patients when combined…
Early data suggests that a combination of temsirolimus and bryostatin may be active in patients with rare forms of renal cell cancer, which are less likely to…
Newcastle University researchers analysed a small clinical trial of losartan, a drug normally prescribed for hypertension, on 14 patients in Spain, who had…
The study evaluated 73 cases in which children younger than two years old were treated for obstructive sleep apnea through the removal of the adenoids,…
“Our study highlights the need for someone who is experiencing the symptoms of a mini-stroke or transient ischemic attack to get to an emergency room fast,”…
The latest advances in polyp detection, assessment of colorectal cancer risk, and patient sedation during colonoscopy will be presented today at Digestive…
When a cancer patient and his or her doctor discuss the value of a treatment option, the conversation usually centers on a consideration of the treatment's…
Researchers at the University of Minnesota Medical School have discovered a new therapy that shows potential to treat people with Duchenne muscular dystrophy,…
Now, for the first time, scientists have discovered a genetic relationship between the two conditions, a researcher told the annual conference of the European…
Statins, a commonly prescribed class of drugs used by millions worldwide to effectively lower blood cholesterol levels, may actually have a negative impact in…
An international team of scientists studying a rare genetic disease discovered that a bundle of proteins with the long-established function of keeping…
Researchers at the National Institute of Environmental Health Sciences (NIEHS), part of the National Institutes of Health, took a lead role in working with the…
The trial determined that patients with chronic lymphocytic leukemia (CLL) can tolerate the chemical fairly well when high doses are administered in capsule…
The new findings, available online and in an upcoming issue of the Proceedings of the National Academy of Sciences, demonstrate that a biochemical system that…